The Charcot foot in diabetes
Gjurain et al., Dig
This supports a clinical approach for accidental exposure focused on risk communication and intensified prenatal monitoring rather than mechanical recommendations for termination
Recently, the pharmacotherapy of MASLD mainly focuses on three parts of mechanisms: anti-inflammatory (ASK1 inhibitors), anti-diabetic (GCGR agonists, PPAR agonists), and prevention of lipotoxicity (FXR agonists, FGF21 analogues) (Wei et al., 2024)
Multiple treatment options available injections (200-1000 g daily) for targeted healing and oral capsules for digestive issues
Research demonstrates GHK-Cu modulates over 4,000 human genes, stimulates collagen I, III, and elastin synthesis, activates matrix metalloproteinases for extracellular matrix remodelling, promotes wound contraction and angiogenesis, and suppresses pro-inflammatory TNF- signalling